Back to Search

BENEDETTO VITIELLO, M.D.

M.D.

Psychiatry Physician

NPI: 1366689929Individual

Specialties, Licenses & Credentials

Psychiatry PhysicianPrimary

Psychiatry & Neurology — Psychiatry

Code: 2084P0800X

D39092(MD)MD19117(DC)

Research & Publications (20)

Treatment of early-onset schizophrenia spectrum disorders (TEOSS): demographic and clinical characteristics.
PMID 17667477·J Am Acad Child Adolesc Psychiatry·2007
2-rct
Treatment of early-onset schizophrenia spectrum disorders (TEOSS): rationale, design, and methods.
PMID 17667476·J Am Acad Child Adolesc Psychiatry·2007
2-rct
Obsessive-compulsive traits in children and adolescents with Asperger syndrome.
PMID 19557496·Eur Child Adolesc Psychiatry·2010
8-other
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
PMID 19223438·Am J Psychiatry·2009
4-observational
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.
PMID 19318991·J Am Acad Child Adolesc Psychiatry·2009
4-observational
Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity.
PMID 18752063·J Autism Dev Disord·2009
2-rct
Suicidal events in the Treatment for Adolescents With Depression Study (TADS).
PMID 19552869·J Clin Psychiatry·2009
2-rct
Combined cognitive-behavioural therapy and pharmacotherapy for adolescent depression: Does it improve outcomes compared with monotherapy?
PMID 19374457·CNS Drugs·2009
8-other
Sources of site differences in the efficacy of a multisite clinical trial: the Treatment of SSRI-Resistant Depression in Adolescents.
PMID 19485586·J Consult Clin Psychol·2009
4-observational
Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns.
PMID 19467582·Eur Neuropsychopharmacol·2009
6-review
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
PMID 19182688·J Am Acad Child Adolesc Psychiatry·2009
4-observational
Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.
PMID 19147693·Am J Psychiatry·2009
2-rct
Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes.
PMID 19127172·J Am Acad Child Adolesc Psychiatry·2009
4-observational
Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial.
PMID 19465880·J Am Acad Child Adolesc Psychiatry·2009
4-observational
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.
PMID 18791817·J Autism Dev Disord·2009
4-observational
Treatment of adolescent depression: what we have come to know.
PMID 19404989·Depress Anxiety·2009
4-observational
Trial design challenges when combining medication and parent training in children with pervasive developmental disorders.
PMID 19096921·J Autism Dev Disord·2009
2-rct
Stimulant treatment of ADHD and risk of sudden death in children.
PMID 19528196·Am J Psychiatry·2009
8-other
Truly independent research? Treatment for Adolescents with Depression Study (TADS).
PMID 18852171·BMJ·2008
8-other
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study.
PMID 18794207·Am J Psychiatry·2008
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
5225 WISCONSIN AVE NW STE 400
WASHINGTON, DC 20015

Location

Practice Location

5225 WISCONSIN AVE NW STE 400, WASHINGTON, DC
(202) 363-1010

Quick Facts

NPI
1366689929
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile